Valeant, Pershing eye shakeup to Allergan board

Thu May 8, 2014 9:01am EDT

May 8 (Reuters) - Deal-making drugmaker Valeant Pharmaceuticals International Inc said on Thursday that it plans with activist investor Pershing Square to pursue a special meeting to change up the board of Allergan Inc , which it hopes to acquire.

Valeant Chief Financial Officer Howard Schiller also said the company is ready to negotiate with Allergan and will commence with Pershing a referendum of Allergan shareholders on support for holding discussions with Valeant. (Reporting by Rod Nickel in Winnipeg, Manitoba, Editing by Franklin Paul)

A couple walks along the rough surf during sunset at Oahu's North Shore, December 26, 2013. REUTERS/Kevin Lamarque

Find your dream retirement town

Florida? Hawaii? Reuters has teamed up with Zillow to give you the power to customize a list of your best places to retire.  Video | Full Article